Congress Asset Management’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-233,009
| Closed | -$3.58M | – | 427 |
|
|
2025
Q4 | $3.58M | Buy |
233,009
+3,434
| +1% | +$37.8K | 0.03% | 250 |
|
|
2025
Q3 | $2.28M | Buy |
229,575
+1,660
| +0.7% | +$17.3K | 0.02% | 276 |
|
|
2025
Q2 | $2.26M | Buy |
227,915
+393
| +0.2% | +$4.14K | 0.02% | 278 |
|
|
2025
Q1 | $2.95M | Sell |
227,522
-1,271
| -0.6% | -$16.8K | 0.02% | 251 |
|
|
2024
Q4 | $2.92M | Buy |
228,793
+19,271
| +9% | +$233K | 0.02% | 262 |
|
|
2024
Q3 | $2.33M | Sell |
209,522
-1,854
| -0.9% | -$20.4K | 0.02% | 267 |
|
|
2024
Q2 | $2.37M | Sell |
211,376
-18,604
| -8% | -$217K | 0.02% | 270 |
|
|
2024
Q1 | $2.85M | Buy |
229,980
+2,845
| +1% | +$37.1K | 0.02% | 259 |
|
|
2023
Q4 | $3.18M | Buy |
227,135
+799
| +0.4% | +$11.1K | 0.03% | 266 |
|
|
2023
Q3 | $3.34M | Buy |
226,336
+310
| +0.1% | +$4.36K | 0.03% | 250 |
|
|
2023
Q2 | $2.92M | Buy |
226,026
+3,136
| +1% | +$35.7K | 0.03% | 260 |
|
|
2023
Q1 | $2.19M | Buy |
222,890
+22,234
| +11% | +$237K | 0.02% | 275 |
|
|
2022
Q4 | $2.13M | Buy |
200,656
+1,895
| +1% | +$22K | 0.02% | 279 |
|
|
2022
Q3 | $2.08M | Buy |
198,761
+2,220
| +1% | +$28.9K | 0.02% | 270 |
|
|
2022
Q2 | $2.47M | Buy |
+196,541
| New | +$2.09M | 0.02% | 259 |
|
Other funds holding DVAX
Congress Asset Management's DVAX Position: Q1 2026 in Review
Congress Asset Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 233,009 shares — an estimated $3.58M sold.
Congress Asset Management first reported a position in DVAX in Q2 2022 and held it in 15 quarters. The position peaked at $3.58M in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- Congress Asset Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- Congress Asset Management sold 233,009 Dynavax Technologies shares in Q1 2026, an estimated $3.58M.
- Congress Asset Management first reported a position in Dynavax Technologies in Q2 2022 and held it in 15 quarters.
- Congress Asset Management's Dynavax Technologies position peaked at $3.58M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on Congress Asset Management's 13F filing for Q1 2026, filed 14 Apr 2026.